Biote Corp. BTMD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $24.12M-38.7% | $39.34M-55.8% | $89M+12.3% | $79.23M+196% | ||
| $31.68M-0.5% | $31.85M-3.4% | $32.97M+44.9% | $22.75M— | ||
| $61.09M-11.7% | $69.17M+52.4% | $45.4M+47.4% | $30.8M— | ||
| $4.62M-26.9% | $6.31M-31.6% | $9.23M+142% | $3.82M-30.3% | ||
| $54.67M-19.8% | $68.13M-44.3% | $122.34M+20.9% | $101.18M+115% | ||
| $10.75M+54.2% | $6.97M+472% | $1.22M-19.0% | $1.5M-35.6% | ||
| $2.7M-16.8% | $3.25M+72.9% | $1.88M-8.5% | $2.05M+476% | ||
| $5.83M0.0% | $5.83M— | —— | —— | ||
| $4.27M-22.4% | $5.5M— | —— | —— | ||
| $24.79M-13.7% | $28.74M+15.5% | $24.88M+1,254% | $1.84M+4,276% | ||
| $72K0.0% | $72K— | —— | —— | ||
| $107.61M-12.1% | $122.37M-21.2% | $155.3M+39.1% | $111.65M+105% | ||
| $6.83M+17.4% | $5.81M+39.9% | $4.16M+1.0% | $4.11M-5.4% | ||
| $9.81M-13.2% | $11.29M+32.9% | $8.5M+35.4% | $6.27M+4.4% | ||
| $3.02M+1.9% | $2.96M-1.4% | $3M+52.8% | $1.97M+15.2% | ||
| $6.25M0.0% | $6.25M0.0% | $6.25M0.0% | $6.25M+25.0% | ||
| $592K+13.2% | $523K+68.2% | $311K+88.5% | $165K-33.5% | ||
| $1.1M-29.4% | $1.55M+17.5% | $1.32M+42.8% | $926K+15.5% | ||
| $44.99M-12.7% | $51.51M+132% | $22.22M+18.4% | $18.77M+8.4% | ||
| $95.78M-5.4% | $101.2M-5.1% | $106.63M-4.9% | $112.09M+251% | ||
| $2.3M-20.5% | $2.89M+72.0% | $1.68M-12.8% | $1.93M+1,417% | ||
| $2.89M-15.3% | $3.41M+71.4% | $1.99M-4.8% | $2.09M+458% | ||
| $344K-77.1% | $1.5M— | —— | —— | ||
| $158.01M-29.6% | $224.57M+17.1% | $191.84M+12.9% | $169.92M+238% | ||
| —— | —— | —— | —— | ||
| $0— | $0— | $0— | $0— | ||
| -$49.55M+50.6% | -$100.3M-241% | -$29.39M+33.9% | -$44.46M-1,167% | ||
| -$29K+17.1% | -$35K-192% | -$12K-140% | -$5K+87.5% | ||
| $8.97M+60.1% | $5.6M— | —— | —— | ||
| $8.14M+118% | $3.73M+152% | -$7.15M+48.3% | -$13.82M— | ||
| -$58.54M+44.7% | -$105.93M-260% | -$29.4M+33.9% | -$44.46M-1,178% | ||
| $107.61M-12.1% | $122.37M-21.2% | $155.3M+39.1% | $111.65M+105% | ||
| $4.53M+16.7% | $3.88M-22.0% | $4.97M-2.0% | $5.07M+11.4% | ||
| $72K0.0% | $72K— | —— | —— | ||
| $2.7M-16.8% | $3.25M+72.9% | $1.88M-8.5% | $2.05M+476% | ||
| $4.53M+16.7% | $3.88M-22.0% | $4.97M-2.0% | $5.07M+11.4% | ||
| $24.79M-13.7% | $28.74M+15.5% | $24.88M+1,254% | $1.84M— | ||
| $4.27M-22.4% | $5.5M— | —— | —— | ||
| $2.7M-16.8% | $3.25M+72.9% | $1.88M-8.5% | $2.05M+476% | ||
| $72K0.0% | $72K— | —— | —— | ||
| $2.7M-16.8% | $3.25M+72.9% | $1.88M-8.5% | $2.05M+476% | ||
| $4.53M+16.7% | $3.88M-22.0% | $4.97M-2.0% | $5.07M+11.4% | ||
| $1.1M-29.4% | $1.55M+17.5% | $1.32M+42.8% | $926K+15.5% | ||
| $9.81M-13.2% | $11.29M+32.9% | $8.5M+35.4% | $6.27M+4.4% | ||
| $9.81M-13.2% | $11.29M+32.9% | $8.5M+35.4% | $6.27M+4.4% | ||
| $18.5M-24.7% | $24.57M— | —— | —— | ||
| $5M— | —— | —— | —— | ||
| $1.1M-29.4% | $1.55M+17.5% | $1.32M+42.8% | $926K+15.5% | ||
| $4.11M-76.0% | $17.14M-58.3% | $41.1M+28.0% | $32.11M— | ||
| $1.1M-29.4% | $1.55M+17.5% | $1.32M+42.8% | $926K+15.5% | ||
| $104.92M-5.4% | $110.86M-3.5% | $114.87M-4.6% | $120.43M+223% | ||
| $8.97M+60.1% | $5.6M— | —— | —— | ||
| $4.11M-76.0% | $17.14M-58.3% | $41.1M+28.0% | $32.11M— | ||
| $5M— | —— | —— | —— | ||
| $8.14M+118% | $3.73M+152% | -$7.15M+48.3% | -$13.82M— | ||
| $4.39M-2.1% | $4.48M-76.3% | $18.89M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biote Corp.'s total assets?
- Biote Corp. (BTMD) holds $89.0M in total assets, down 27.8% year over year.
- How much debt does Biote Corp. have?
- Biote Corp. carries $103.4M in total debt against -$56.1M of shareholders' equity, a debt-to-equity ratio of 9.05.
- How much cash does Biote Corp. have?
- Biote Corp. holds $5.3M in cash and equivalents.
- Can Biote Corp. cover its short-term obligations?
- Its current ratio is 1.29 — current assets exceed current liabilities.
- Where does Biote Corp.'s balance sheet data come from?
- Every line is extracted from Biote Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
